SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-084377
Filing Date
2016-11-01
Accepted
2016-11-01 16:11:17
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 EDGE THERAPEUTICS, INC. 10-Q 9-30-2016 form10q.htm 10-Q 542259
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 358114
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 12306
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12322
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4997
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 4846
  Complete submission text file 0001140361-16-084377.txt   3593725

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT edge-20160930.xml EX-101.INS 480624
8 XBRL TAXONOMY EXTENSION SCHEMA edge-20160930.xsd EX-101.SCH 29987
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20160930_cal.xml EX-101.CAL 41881
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20160930_def.xml EX-101.DEF 139769
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20160930_lab.xml EX-101.LAB 512892
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20160930_pre.xml EX-101.PRE 257722
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 161964893
SIC: 2834 Pharmaceutical Preparations